2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with dactinomycin in 1 studies
| Studies (2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine) | Trials (2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine) | Recent Studies (post-2010) (2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 46 | 0 | 7 | 19,045 | 355 | 969 |
| Protein | Taxonomy | 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crane-Godreau, MA; Wira, CR | 1 |
1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and dactinomycin
| Article | Year |
|---|---|
CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys.
Topics: Animals; Cell Polarity; Cells, Cultured; Chemokine CCL20; Chemokines, CC; Cysteine; Dactinomycin; Epithelial Cells; Female; Lipopolysaccharides; Lipoproteins; Macrophage Inflammatory Proteins; Membrane Glycoproteins; Rats; Rats, Inbred Lew; Receptors, Cell Surface; Teichoic Acids; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Uterus | 2005 |